Sign up to save your podcasts
Or
Share Episode 2. Centralised and Decentralised Procedures
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Episode 2. Centralised and Decentralised Procedures
Different approval pathways can be explored while entering the European pharmaceutical market. The approval pathways include:
- Centralized Procedure (CP)
Our experts discuss the most explored pathways, CP and DCP, and the eligibility criteria to pursue them for product approval and marketing authorization within the European Union (EU).
Reference Links
- EMA overview of the centralised authorisation procedure
View all episodes
By Freyr SolutionsDifferent approval pathways can be explored while entering the European pharmaceutical market. The approval pathways include:
- Centralized Procedure (CP)
Our experts discuss the most explored pathways, CP and DCP, and the eligibility criteria to pursue them for product approval and marketing authorization within the European Union (EU).
Reference Links
- EMA overview of the centralised authorisation procedure